| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | ORY-1001 |
|---|
| Description | ORY-1001 is a potent and selective inhibitor of LSD1 (IC50 < 20 nM). It targets acute myeloid leukemia (AML) stem cells and significantly reduces tumor cell load while increasing survival time in mouse models of AML. ORY-1001 is in clinical trials for cancer treatment. MW: 303.27. Purity ≥98% by HPLC |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine, dihydrochloride; RG-6016 |
|---|
| Gene, Accession, CAS # | CAS: 1431326-61-2 |
|---|
| Catalog # | B1957-1 |
|---|
| Price | |
|---|
| Order / More Info | ORY-1001 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|